NCT03527381View on ClinicalTrials.gov

Nitric Oxide in Cardiopulmonary Bypass for Renal Protection in Cardiac Surgery

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

September 1, 2015

Primary Completion Date

December 25, 2016

Study Completion Date

April 14, 2017

Conditions
Coronary Artery DiseaseHeart Valve DiseasesCardiomyopathiesAcute Kidney Injury
Interventions
DRUG

Nitric Oxide

40 ppm of exogenous gaseous nitric oxide is supplied directly to the oxygenator in the cardiopulmonary bypass circuit during cardiac surgery.

OTHER

Standard CPB

Standard CPB protocol of delivery of air gas mixture to the cardiopulmonary bypass circuit during cardiac surgery.

All Listed Sponsors
lead

Nikolay Kamenshchikov

OTHER

NCT03527381 - Nitric Oxide in Cardiopulmonary Bypass for Renal Protection in Cardiac Surgery | Biotech Hunter | Biotech Hunter